Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Timing matters when it comes to retirement planning. Learn when you should start planning to maximize your savings and ensure a secure future.
26,056 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Casey’s General Stores posted stronger fuel margins and a growing Rewards base, lifting investor optimism. Analysts c...
Moscow Exchange is set to publish an official XRP index as part of a broader crypto expansion that will also cover SO...
Remax Holdings posted a revenue decline and a sharper net loss in Q1 2026, while debt rose to $436 million. Real Brok...
A fresh Mizuho note raises Intel's price target to $124 on AI server demand, signaling renewed confidence in the turn...
Tesla sits around $445 as Q1 margin gains meet AI roadmap momentum, prompting fresh Buy, Sell or Hold questions for i...
Japan’s Toto, the top bidet maker, has long supplied precision chip components. Now investors are connecting Toto to ...
XRP stalls after a rejection at the 100-day moving average, with price around $1.37 as bulls weigh the next move. Key...
As 2026’s stock-split wave unfolds, investors eye three high-profile names—AutoZone, Grainger, and United Rentals—for...
Digital mortgage tools are reshaping how buyers shop for homes as rates swing and inventories stay tight. The latest ...
Snowflake delivered a monster quarter, beating expectations and setting the stage for a new era in software pricing d...
Microsoft and Apple are rolling out platform-native features at Build and WWDC that could squeeze rival apps. Investo...